Wednesday 20 September 2017

Growth of Parkinsons Disease Market in Global Industry : Overview, Size and Share 2017

ResearchMoz presents professional and in-depth study of "Global Parkinsons Disease Market Report: 2016 Edition".

Parkinsons Disease (PD) is a chronic and progressive neurodegenerative or movement disorder which involves the malfunction and death of vital nerve cells in the brain, called neurons. Parkinsons primarily affects neurons in an area of the brain called the “substantia nigra”. The early signs and symptoms may be mild and may go unnoticed initially. The cause of this disease is mainly unknown with no cure till date but there exist several treatment options such as medications and surgery.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=715352

The current treatment market for Parkinsons disease has several unmet needs as no treatment has yet been successful in fully restoring the function that produces dopamine. However, the treatment currently only aims at controlling and relieving symptoms. The Parkinsons disease treatment market remains flooded by both branded and generic drugs. The market is expected to experience fluctuations in branded sales due to patent expiries and subsequent entry of generics in the market. Several biologics are under development for the treatment of Parkinsons along with possibility of developing “Stem Cell” as a treatment therapy.

The Parkinsons disease market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing healthcare expenditure and ageing population. The major growth drivers of the Parkinsons disease market includes rising level of toxin exposure, increasing life expectancy, rising male population worldwide, ageing population, healthcare expenditure and pesticide consumption. However, the growth of the market will also remain challenged by generic erosion, current treatment limitations and increasing risk of developing Melanoma.

The report, “Global Parkinsons disease Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific markets of the U.S., the European Union and Japan are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth. 

Table of Content

1. Market Overview
1.1 Introduction   
1.2 Fundamental Features   
1.3 Types of Parkinson’s Disease   
1.4 Risk Factors   
1.5 Treatment Options

Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=715352

2. Global Market
2.1 Global Parkinson’s Disease Drug Market by Value   
2.1.1 Global Parkinson’s Disease Drug Market by Region   
2.1.2 Global Parkinson’s Disease Market by Drug Class   
2.1.3 Global Parkinson’s Disease Patient Population by Severity   
2.1.4 Global Parkinson’s Disease Patient Population by Region

3. Regional Markets
3.1 The U.S.   
3.1.1 The U.S. Parkinson’s Disease Market by Value & Volume   
3.1.2 The U.S. Parkinson’s Disease Market Value by Category   
3.1.3 The U.S. Parkinson’s Disease Market Volume by Category   
3.1.4 The U.S. Parkinson’s Disease Market by Drug Class   
3.1.5 The U.S. Parkinson’s Disease Branded Drugs Market   
3.1.6 The U.S. Parkinson’s Disease Generic Drugs Market   
3.2 The European Union   
3.2.1 The E.U. Parkinson’s Patient Prevalence & Diagnosis
3.2.2 The European Parkinson’s Disease Drug Market by Value   
3.3 Japan   
3.3.1 Japan’s Parkinson’s Disease Drug Market by Value

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Level of Toxin Exposure   
4.1.2 Rising Life Expectancy   
4.1.3 Rising Male Population   
4.1.4 Increasing Ageing Population   
4.1.5 Global Healthcare Expenditure   
4.1.6 Pesticides Consumption
4.2 Trends

Browse Report @ http://www.researchmoz.us/global-parkinsons-disease-market-report-2016-edition-report.html

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

No comments:

Post a Comment